Isabelle Pouliquen

A Phase I Trial of a Potent P-Glycoprotein Inhibitor, Zosuquidar Trihydrochloride (LY335979), Administered Intravenously in Combination with Doxorubicin in Patients with Advanced Malignancy

Alan Sandler, Michael A. Gordon, Dinesh P. de Alwis et al. · Clinical Cancer Research · 2004 · 150 citations · Full text

Efficacy and safety of an anti–IL-13 mAb in patients with severe asthma: A randomized trial

Erika H. De Boever, Claire Ashman, Anthony Cahn et al. · Journal of Allergy and Clinical Immunology · 2014 · 142 citations

Clinical Immunology, Asthma, Allergy +10

Subcutaneous mepolizumab in children aged 6 to 11 years with severe eosinophilic asthma

Atul Gupta, Isabelle Pouliquen, Daren Austin et al. · Pediatric Pulmonology · 2019 · 86 citations · Full text

Characterization of the relationship between dose and blood eosinophil response following subcutaneous administration of mepolizumab

Isabelle Pouliquen, Oliver Kornmann, Sharon V. Barton et al. · International Journal of Clinical Pharmacology and Therapeutics · 2015 · 83 citations · Full text

A phase 1, randomized, placebo‐controlled, dose‐escalation study of an anti‐IL‐13 monoclonal antibody in healthy subjects and mild asthmatics

Peter Hodsman, Claire Ashman, Anthony Cahn et al. · British Journal of Clinical Pharmacology · 2012 · 57 citations · Full text